Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality.

Seppälä, Ilkka; Kleber, Marcus E.; Lyytikäinen, Leo-Pekka; Hernesniemi, Jussi A.; Mäkelä, Kari-Matti; Oksala, Niku; Laaksonen, Reijo; Pilz, Stefan; Tomaschitz, Andreas; Silbernagel, Günther; Boehm, Bernhard O.; Grammer, Tanja B.; Koskinen, Tuomas; Juonala, Markus; Hutri-Kähönen, Nina; Alfthan, Georg; Viikari, Jorma S. A.; Kähonen, Mika; Raitakari, Olli T.; März, Winfried; ... (2014). Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality. European Heart Journal, 35(8), pp. 524-531. Oxford University Press 10.1093/eurheartj/eht447

[img]
Preview
Text
eht447.pdf - Published Version
Available under License Publisher holds Copyright.

Download (496kB) | Preview

AIMS The purpose of this study was to identify novel genetic variants influencing circulating asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) levels and to evaluate whether they have a prognostic value on cardiovascular mortality. METHODS AND RESULTS We conducted a genome-wide association study on the methylarginine traits and investigated the predictive value of the new discovered variants on mortality. Our meta-analyses replicated the previously known locus for ADMA levels in DDAH1 (rs997251; P = 1.4 × 10(-40)), identified two non-synomyous polymorphisms for SDMA levels in AGXT2 (rs37369; P = 1.4 × 10(-40) and rs16899974; P = 1.5 × 10(-38)) and one in SLC25A45 (rs34400381; P = 2.5 × 10(-10)). We also fine-mapped the AGXT2 locus for further independent association signals. The two non-synonymous AGXT2 variants independently associated with SDMA levels were also significantly related with short-term heart rate variability (HRV) indices in young adults. The major allele (C) of the novel non-synonymous rs16899974 (V498L) variant associated with decreased SDMA levels and an increase in the ratio between the low- and high-frequency spectral components of HRV (P = 0.00047). Furthermore, the SDMA decreasing allele (G) of the non-synomyous SLC25A45 (R285C) variant was associated with a lower resting mean heart rate during the HRV measurements (P = 0.0046), but not with the HRV indices. None of the studied genome-wide significant variants had any major effect on cardiovascular or total mortality in patients referred for coronary angiography. CONCLUSIONS AGXT2 has an important role in SDMA metabolism in humans. AGXT2 may additionally have an unanticipated role in the autonomic nervous system regulation of cardiac function.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology

UniBE Contributor:

Silbernagel, Günther

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0195-668X

Publisher:

Oxford University Press

Language:

English

Submitter:

Catherine Gut

Date Deposited:

09 Oct 2014 09:21

Last Modified:

26 Oct 2019 06:43

Publisher DOI:

10.1093/eurheartj/eht447

PubMed ID:

24159190

Uncontrolled Keywords:

Asymmetric dimethylarginine, Genetics, Genome-wide association study, Heart rate variability, Mortality, Sudden cardiac death, Symmetric dimethylarginine

BORIS DOI:

10.7892/boris.50738

URI:

https://boris.unibe.ch/id/eprint/50738

Actions (login required)

Edit item Edit item
Provide Feedback